India’s Draft Guidelines For COVID-19 Vaccines Follow WHO, US Lead

Primary Endpoint Efficacy 50%, Secondary Up To 30%

 
• By Vibha Ravi
Guidelines
India's COVID-19 Vaccine Guidelines Address A Host Of Aspects • Source: Shutterstock

More from Clinical Trials

More from R&D